Related Experiment Videos
A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles.
Xiaojun Zhao1, Lisa R Hilliard, Shelly John Mechery
1Center for Research at the Bio/Nano Interface, Department of Chemistry, and The Shands Cancer Center, University of Florida, Gainesville, FL 32611, USA.
Summary
We developed a rapid, ultrasensitive nanoparticle bioassay for detecting single bacteria in under 20 minutes. This technology offers high-throughput pathogen quantification for biotechnology and medical diagnostics.
Area of Science:
- Nanotechnology
- Bioconjugation
- Biosensing
Background:
- Rapid and sensitive pathogenic bacteria detection is crucial for biotechnology, medical diagnostics, and bioterrorism defense.
- Existing methods often lack ultrasensitivity or require lengthy analysis times.
- There is a need for faster, more sensitive pathogen detection systems.
Purpose of the Study:
- To develop a novel bioconjugated nanoparticle-based bioassay for rapid, in situ pathogen quantification.
- To achieve single-bacterium detection sensitivity within a 20-minute timeframe.
- To demonstrate the assay's potential for high-throughput and practical applications.
Main Methods:
- Utilized antibody-conjugated nanoparticles for specific bacterial identification via antibody-antigen interactions.
- Employed two independent optical techniques to confirm single-bacterium detection.
- Validated the assay using a 384-well microplate format for high-throughput analysis.
- Tested the assay's efficacy by detecting Escherichia coli O157:H7 in spiked food samples.
Main Results:
- Achieved ultrasensitive pathogen quantification down to single bacterium within 20 minutes.
- Demonstrated high specificity and sensitivity using antibody-conjugated nanoparticles.
- Confirmed single-bacterium detection capability through plate-counting and optical methods.
- Successfully detected low concentrations (1-400 cells) of E. coli O157 in ground beef samples.
- Showcased high-throughput analysis using a 384-well microplate format.
Conclusions:
- Bioconjugated nanoparticles offer a powerful platform for ultrasensitive and rapid biodetection.
- The developed bioassay has broad potential in biotechnology, medical diagnostics, and biodetection systems.
- Integration of bionanotechnology provides a revolutionary tool for detecting disease markers and infectious agents.